These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29263166)

  • 1. Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.
    Hu C; Jia W
    Diabetes; 2018 Jan; 67(1):3-11. PubMed ID: 29263166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.
    Wang X; Strizich G; Hu Y; Wang T; Kaplan RC; Qi Q
    J Diabetes; 2016 Jan; 8(1):24-35. PubMed ID: 26119161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes.
    Sirdah MM; Reading NS
    Clin Genet; 2020 Dec; 98(6):525-547. PubMed ID: 32385895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of type 2 diabetes in European populations.
    Qi Q; Hu FB
    J Diabetes; 2012 Sep; 4(3):203-12. PubMed ID: 22781158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic-risk assessment of GWAS-derived susceptibility loci for type 2 diabetes in a 10 year follow-up of a population-based cohort study.
    Go MJ; Lee Y; Park S; Kwak SH; Kim BJ; Lee J
    J Hum Genet; 2016 Dec; 61(12):1009-1012. PubMed ID: 27439680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population.
    Qian Y; Dong M; Lu F; Li H; Jin G; Hu Z; Shen C; Shen H
    Mol Cell Endocrinol; 2015 May; 407():46-51. PubMed ID: 25749274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach.
    Pretorius E; Bester J
    Oncotarget; 2016 Aug; 7(32):50895-50907. PubMed ID: 27447972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic advances of type 2 diabetes in Chinese populations.
    Yu W; Hu C; Jia W
    J Diabetes; 2012 Sep; 4(3):213-20. PubMed ID: 22781187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 Diabetes, Diabetes Genetic Score and Risk of Decreased Renal Function and Albuminuria: A Mendelian Randomization Study.
    Xu M; Bi Y; Huang Y; Xie L; Hao M; Zhao Z; Xu Y; Lu J; Chen Y; Sun Y; Qi L; Wang W; Ning G
    EBioMedicine; 2016 Apr; 6():162-170. PubMed ID: 27211558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G.G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India.
    Sokhi J; Sikka R; Raina P; Kaur R; Matharoo K; Arora P; Bhanwer A
    Mol Genet Genomics; 2016 Feb; 291(1):205-16. PubMed ID: 26251103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
    Aghaei Meybodi HR; Hasanzad M; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes.
    O'Connell TM; Markunas CA
    Curr Diabetes Rev; 2016; 12(1):20-9. PubMed ID: 25981498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes.
    Vaag A; Brøns C; Gillberg L; Hansen NS; Hjort L; Arora GP; Thomas N; Broholm C; Ribel-Madsen R; Grunnet LG
    Acta Obstet Gynecol Scand; 2014 Nov; 93(11):1099-108. PubMed ID: 25179736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine in diabetes mellitus: current opportunities and future prospects.
    Kleinberger JW; Pollin TI
    Ann N Y Acad Sci; 2015 Jun; 1346(1):45-56. PubMed ID: 25907167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Type 2 diabetes.
    Barroso I
    Diabet Med; 2005 May; 22(5):517-35. PubMed ID: 15842505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of type 2 diabetes in the Chinese Northern Han population: a case-control study and meta-analysis.
    Zhou JB; Yang JK; Zhao L; Xin Z
    Med Sci Monit; 2010 Jun; 16(6):BR179-83. PubMed ID: 20512086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
    Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
    Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions and type 2 diabetes.
    Geng T; Huang T
    Asia Pac J Clin Nutr; 2020; 29(2):220-226. PubMed ID: 32674227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An explained variance-based genetic risk score associated with gestational diabetes antecedent and with progression to pre-diabetes and type 2 diabetes: a cohort study.
    Cormier H; Vigneault J; Garneau V; Tchernof A; Vohl MC; Weisnagel SJ; Robitaille J
    BJOG; 2015 Feb; 122(3):411-9. PubMed ID: 25041170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Genetic Risk and Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study.
    Inaishi J; Hirakawa Y; Horikoshi M; Akiyama M; Higashioka M; Yoshinari M; Hata J; Mukai N; Kamatani Y; Momozawa Y; Kubo M; Ninomiya T
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3213-3222. PubMed ID: 30830152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.